Franklin Resources
ORIC icon

Franklin Resources’s Oric Pharmaceuticals ORIC Stock Holding History

Franklin Resources’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Buy
1,797,377
+344,542
+24% +$3.12M ﹤0.01% 1015
2026
Q1 		$18.4M Buy
1,452,835
+240,288
+20% +$2.73M ﹤0.01% 1017
2025
Q4 		$9.92M Buy
1,212,547
+31,218
+3% +$359K ﹤0.01% 1164
2025
Q3 		$14.2M Buy
1,181,329
+138,771
+13% +$1.46M ﹤0.01% 1064
2025
Q2 		$10.6M Buy
1,042,558
+19,768
+2% +$133K ﹤0.01% 1110
2025
Q1 		$5.71M Buy
1,022,790
+72,268
+8% +$632K ﹤0.01% 1301
2024
Q4 		$7.67M Buy
950,522
+63
+0% +$578 ﹤0.01% 1205
2024
Q3 		$9.07M Buy
950,459
+196,804
+26% +$1.95M ﹤0.01% 1160
2024
Q2 		$5.33M Buy
753,655
+3,139
+0.4% +$28.1K ﹤0.01% 1288
2024
Q1 		$10.3M Hold
750,516
– – ﹤0.01% 1069
2023
Q4 		$6.9M Buy
750,516
+105
+0% +$759 ﹤0.01% 1035
2023
Q3 		$4.54M Buy
750,411
+732,487
+4,087% +$6M ﹤0.01% 1114
2023
Q2 		$139K Buy
+17,924
New +$102K ﹤0.01% 2471
2020
Q3 		– Sell
-125,000
Closed -$3.2M – 1890
2020
Q2 		$3.2M Buy
+125,000
New +$3.99M ﹤0.01% 1065

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources's ORIC Position: Q2 2026 in Review

Franklin Resources increased its Oric Pharmaceuticals (ORIC) stake by 24% in Q2 2026, buying an estimated $3.12M and bringing the position to 1,797,377 shares worth $19.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

Franklin Resources first reported a position in ORIC in Q2 2020 and has held it in 14 quarters since. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Franklin Resources held 1,797,377 shares of Oric Pharmaceuticals worth $19.5M as of Q2 2026.
  • Franklin Resources bought 344,542 Oric Pharmaceuticals shares in Q2 2026, an estimated $3.12M.
  • Oric Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1015 holding.
  • Franklin Resources first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 14 quarters since.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.